
Cat. #154785
Anti-CD44 [NKI-P1]
Cat. #: 154785
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 3-4 weeks
Target: CD44
Class: Monoclonal
Application: FACS ; IHC ; IP
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: Netherlands Cancer Institute
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-CD44 [NKI-P1]
- Alternate name: Hematopoietic Cell E- And L-Selectin Ligand; Heparan Sulfate Proteoglycan; Hermes Antigen
- Research fields: Cell biology;Immunology
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 84 kDa
- Strain: Balb/c
- Reactivity: Human
- Host: Mouse
- Application: FACS ; IHC ; IP
- Description: CD44 antigen is a cell-surface glycoprotein involved in cellÄËĂÂĂÂcell interactions, cell adhesion and migration. CD44 is expressed in a large number of mammalian cell types and participates in a wide variety of cellular functions including lymphocyte activation, recirculation and homing, haematopoiesis, and tumour metastasis.
- Immunogen: A mouse was immunized rasplenically with immunoprecipitated LFA-I family antigen. The immunoprecipitates were obtained from lysates of human monocytes by centrifugal elutriation (>90% pure).
- Isotype: IgG1
- Myeloma used: Sp2/0-Ag14
Target Details
- Target: CD44
- Molecular weight: 84 kDa
- Target background: CD44 antigen is a cell-surface glycoprotein involved in cellcell interactions, cell adhesion and migration. CD44 is expressed in a large number of mammalian cell types and participates in a wide variety of cellular functions including lymphocyte activation, recirculation and homing, haematopoiesis, and tumour metastasis.
Applications
- Application: FACS ; IHC ; IP
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Dry ice
References
- Pals et al. 1989. J Immunol. 143(3):851-7. PMID: 2663988.
![Anti-CAR Whitlow Linker [1C3C3]](https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-300x322.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-280x300.jpg 280w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-954x1024.jpg 954w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-768x824.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 1193w)

![Anti-CAR Whitlow Linker [1B4A1]](https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-300x396.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-227x300.jpg 227w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-776x1024.jpg 776w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-768x1013.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 970w)
